ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
PremiumPress ReleasesADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
1M ago
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Premium
Press Releases
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
2M ago
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
Premium
Press Releases
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
2M ago
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
PremiumPress ReleasesADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
3M ago
ADC Therapeutics set to join Russell 2000, Russell 3000 Indexes
Premium
The Fly
ADC Therapeutics set to join Russell 2000, Russell 3000 Indexes
3M ago
ADC Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
ADC Therapeutics participates in a conference call with JPMorgan
3M ago
ADC Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyADC Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
ADC Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
ADC Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Premium
Press Releases
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100